Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study
Bruera, E, Ernst, S, Hagen, N, Spachynski, K, Belzile, M, Hanson, J, Summers, N, Brown, B, Dulude, H, Gallant, G
Published in Cancer prevention & control (01.04.1998)
Get more information
Published in Cancer prevention & control (01.04.1998)
Journal Article
A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)
WARNER, E, GOEL, R, GALLANT, G, CHANG, J, CHOW, W, VERMA, S, DANCEY, J, FRANSSEN, E, DULUDE, H, GIROUARD, M, CORREIA, J
Published in British journal of cancer (01.06.1998)
Published in British journal of cancer (01.06.1998)
Get full text
Journal Article
A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer
Glück, S, Germond, C, Lopez, P, Cano, P, Dorreen, M, Koski, T, Arnold, A, Dulude, H, Gallant, G
Published in European journal of cancer (1990) (01.06.1998)
Published in European journal of cancer (1990) (01.06.1998)
Get full text
Journal Article
A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
Gelmon, K. A., Tolcher, A., O'Reilly, S., Campbell, C., Bryce, C., Shenkier, T., Ragaz, J., Ayers, D., Nakashima, L., Rielly, S., Dulude, H.
Published in Annals of oncology (01.11.1998)
Published in Annals of oncology (01.11.1998)
Get full text
Journal Article
A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix
Trudeau, M., Seymour, R., Stanimir, G., Souhami, L., Arthur, L., Dulude, H., Gallant, G., Leyland-Jones, B.
Published in International journal of gynecological cancer (01.05.2000)
Published in International journal of gynecological cancer (01.05.2000)
Get more information
Journal Article
Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer
Evans, W.K, Earle, C.C, Stewart, D.J, Dahrouge, S, Tomiak, E, Goss, G, Logan, D, Goel, R, Gertler, S.Z, Dulude, H
Published in Lung cancer (Amsterdam, Netherlands) (01.08.1997)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.1997)
Get full text
Journal Article
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis
Nam, Robert K, Reeves, Jonathan R, Toi, Ants, Dulude, Helene, Trachtenberg, John, Emami, Marjan, Daigneault, Luc, Panchal, Chandra, Sugar, Linda, Jewett, Michael A S, Narod, Steven A
Published in The Journal of urology (01.04.2006)
Published in The Journal of urology (01.04.2006)
Get more information
Journal Article
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis
Annabi, Borhane, Bouzeghrane, Mounia, Currie, Jean-Christophe, Hawkins, Robert, Dulude, Hélène, Daigneault, Luc, Ruiz, Marcia, Wisniewski, Jan, Garde, Seema, Rabbani, Shafaat A, Panchal, Chandra, Wu, Jinzi J, Béliveau, Richard
Published in Clinical & experimental metastasis (01.09.2005)
Published in Clinical & experimental metastasis (01.09.2005)
Get full text
Journal Article
Prognostic value of serum PSP94 (prostate secretory protein of 94 amino acids) and its binding protein (PSPBP) after radical prostatectomy
Reeves, J. R., Dulude, H., Panchal, C., Daigneault, L., Ramnani, D. M., Xuan, J. W.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase I trial results of PCK3145 in patients (pts) with castrate metastatic prostate cancer (PC)—The US experience
Slovin, S. F., Daigneault, L., Dulude, H., Panchal, C., Richardson, J., Curley, T., Delacruz, A., Fleisher, M., Morris, M., Scher, H.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
A multiple ascending dose, open-label, phase IIa study evaluating the safety and tolerability of PCK3145 administered intravenously in patients with metastatic hormone refractory prostate cancer (HRPC)
Hawkins, R., Panchal, C., Dulude, H., Cowan, R., Armstrong, A., Fenemore, J., Daigneault, L.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A multiple ascending dose, open-label, phase IIa study evaluating the safety and tolerability of PCK3145 administered intravenously in patients with metastatic hormone refractory prostate cancer (HRPC)
Hawkins, R., Panchal, C., Dulude, H., Cowan, R., Armstrong, A., Fenemore, J., Daigneault, L.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer
Daigneault, L., Panchal, C., Scher, H. I., Slovin, S. F., Rabbani, S., Dulude, H., Garde, S., Ruiz, M., Wu, J., Hawkins, R.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
A phase I/II study of paclitaxel (Taxol ®) and concurrent radiotherapy in advanced nonsmall cell lung cancer
Kirkbride, Peter, Gelmon, Karen, Eisenhauer, Elizabeth, Fisher, Bryn, Dulude, Hélène
Published in International journal of radiation oncology, biology, physics (01.12.1997)
Published in International journal of radiation oncology, biology, physics (01.12.1997)
Get full text
Journal Article
Phase I/II study of biweekly paclitaxel and cisplatin in nonsmall cell lung cancer (NSCLC). Final result with QOL data
Melosky, B, Gelmon, K.A, Murray, N, Page, R, Ayers, D, Lee, C, Reilly, S, Dulude, H
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2000)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2000)
Get full text
Journal Article